Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 137.31M | 127.95M | 138.53M | 127.28M | 191.60M |
Gross Profit | 110.48M | 93.28M | 96.61M | 86.91M | 147.03M |
EBITDA | -9.27M | -11.74M | 9.18M | 36.33M | -69.42M |
Net Income | -48.10M | -42.86M | -40.72M | -22.75M | -146.69M |
Balance Sheet | |||||
Total Assets | 597.14M | 644.02M | 714.81M | 806.16M | 794.30M |
Cash, Cash Equivalents and Short-Term Investments | 23.56M | 13.78M | 14.42M | 17.57M | 31.83M |
Total Debt | 93.60M | 65.69M | 69.28M | 134.93M | 122.74M |
Total Liabilities | 198.20M | 182.71M | 200.00M | 274.21M | 263.77M |
Stockholders Equity | 400.19M | 462.56M | 516.02M | 532.93M | 531.06M |
Cash Flow | |||||
Free Cash Flow | 3.52M | 4.25M | -1.12M | 6.20M | 22.32M |
Operating Cash Flow | 6.39M | 6.18M | 1.60M | 10.36M | 29.68M |
Investing Cash Flow | 22.56M | 3.11M | 82.28M | 4.71M | -5.73M |
Financing Cash Flow | -18.74M | -8.63M | -88.23M | -29.31M | -25.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $43.44B | 13.26 | 11.92% | 3.76% | 1.85% | -6.19% | |
77 Outperform | $152.16B | 18.66 | 203.51% | 11.11% | 6.04% | 50.60% | |
74 Outperform | HK$254.13B | 15.15 | 28.11% | 0.03% | 11.51% | 47.88% | |
73 Outperform | $122.82B | 17.35 | 20.60% | 0.06% | 14.60% | 24.66% | |
66 Neutral | £10.55B | 8.63 | 3.35% | 3.46% | -1.40% | 17.93% | |
53 Neutral | HK$35.99M | ― | -15.73% | ― | -9.65% | -36.30% | |
40 Underperform | HK$74.85M | ― | ― | -13.11% | -117.15% |